Related Experiment Video

Updated: Aug 2, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Thromboxane biosynthesis in cardiovascular diseases

C Patrono1, G Ciabattoni, G Davi

  • 1Department of Pharmacology, Catholic University School of Medicine, Rome, Italy.

Stroke
|December 1, 1990
PubMed

Insights

Sudden plaque fissuring can cause transient ischemia, with enhanced thromboxane A2 (TXA2) biosynthesis contributing to platelet activation. Aspirin therapy effectively reduces thrombotic events in conditions like unstable angina and myocardial infarction.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis and Hemostasis
  • Pharmacology

Background:

  • Atherosclerotic plaque fissuring is a proposed trigger for transient ischemic events in coronary and cerebral circulation.
  • Enhanced thromboxane A2 (TXA2) biosynthesis is implicated in platelet activation at acute vascular lesions, evidenced by metabolite excretion in unstable angina.
  • Aspirin (75-325 mg/day) reduces thrombotic events in unstable angina and acute myocardial infarction, suggesting a role for TXA2 in these conditions.

Purpose of the Study:

  • To investigate the role of thromboxane A2 (TXA2) in acute vascular events and metabolic abnormalities.
  • To evaluate the impact of Aspirin therapy on TXA2-mediated platelet activation and thrombotic risk.
  • To explore the potential of low-dose Aspirin and TXA2-receptor antagonists in managing metabolic conditions with high thrombotic risk.

Main Methods:

  • Measurement of urinary 11-dehydro-TXB2 and 2,3-dinor-TXB2 metabolites.
  • Analysis of Aspirin trial data (e.g., ISIS-2).
  • Assessment of TXA2 biosynthesis and platelet function in conditions like unstable angina, myocardial infarction, percutaneous transluminal coronary angioplasty, diabetes mellitus, and hypercholesterolemia.

Main Results:

  • Episodic increases in TXA2 metabolite excretion are observed in unstable angina and during percutaneous transluminal coronary angioplasty.
  • Short-term Aspirin therapy shows significant impact on thrombotic events in acute myocardial infarction.
  • Non-insulin-dependent diabetes mellitus and type IIa hypercholesterolemia exhibit persistent TXA2-dependent platelet abnormalities, responsive to low-dose Aspirin (50 mg/day).

Conclusions:

  • TXA2-mediated platelet activation plays a significant role in both acute vascular events and chronic metabolic abnormalities.
  • Aspirin therapy is effective in mitigating TXA2-driven thrombotic complications.
  • Low-dose Aspirin and selective TXA2-receptor antagonists warrant further investigation for managing thrombotic risk in diabetes and hypercholesterolemia.

More Related Videos

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...